Access Bio (Korea) Analysis
| 950130 Stock | KRW 5,780 210.00 3.77% |
Access Bio is overvalued with Real Value of 5098.8 and Hype Value of 5780.0. The main objective of Access Bio stock analysis is to determine its intrinsic value, which is an estimate of what Access Bio is worth, separate from its market price. There are two main types of Access Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Access Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Access Bio's stock to identify patterns and trends that may indicate its future price movements.
The Access Bio stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Access Bio's ongoing operational relationships across important fundamental and technical indicators.
Access |
Access Stock Analysis Notes
About 25.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 149.71. Access Bio had not issued any dividends in recent years. Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. For more info on Access Bio please contact YoungHo Choi at 732 873 4040 or go to http://www.accessbiodiagnostics.net.Access Bio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Access Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Access Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Access Bio generated a negative expected return over the last 90 days | |
| About 25.0% of the company shares are owned by insiders or employees |
Access Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 292.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Access Bio's market, we take the total number of its shares issued and multiply it by Access Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Access Profitablity
Access Bio's profitability indicators refer to fundamental financial ratios that showcase Access Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Access Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Access Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Access Bio's profitability requires more research than a typical breakdown of Access Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.4 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.55 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.55. Technical Drivers
As of the 26th of November, Access Bio shows the risk adjusted performance of (0.16), and Mean Deviation of 2.11. Access Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Access Bio Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Access Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Access Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Access Bio Outstanding Bonds
Access Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Access Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Access bonds can be classified according to their maturity, which is the date when Access Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Access Bio Predictive Daily Indicators
Access Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Access Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0536 | |||
| Daily Balance Of Power | 0.6774 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 5625.0 | |||
| Day Typical Price | 5676.67 | |||
| Market Facilitation Index | 310.0 | |||
| Price Action Indicator | 260.0 | |||
| Period Momentum Indicator | 210.0 |
Access Bio Forecast Models
Access Bio's time-series forecasting models are one of many Access Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Access Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Access Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Access Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Access shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Access Bio. By using and applying Access Stock analysis, traders can create a robust methodology for identifying Access entry and exit points for their positions.
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Access Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |